Patents by Inventor Timothy A. Chan

Timothy A. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11205510
    Abstract: Disclosed herein are various embodiments of systems and methods for visualizing, analyzing, and managing telepresence devices operating in a telepresence network of healthcare facilities. The visualization and management system for telepresence devices may display a first viewing level that includes a geographical representation of the location of various telepresence devices. A user may selectively view a global view of all telepresence devices, telepresence devices within a particular region, and/or the details of a particular telepresence device. A user may also access a viewing level of a network of healthcare facilities. The user may view, analyze, and/or manage the healthcare network, telepresence device network, individual telepresence devices, connection rules, and/or other aspects of the healthcare network using the geographical visualization and management tool described herein.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: December 21, 2021
    Assignee: TELADOC HEALTH, INC.
    Inventors: Scott Ross, Kelton Temby, Jonathan Southard, Dan Habecker, Michael Chan, Timothy C. Wright, Charles S. Jordan, Joshua A. Bouganim
  • Patent number: 11202855
    Abstract: This invention discloses methods for reducing physiologic molecules in abnormal levels and/or exogenous toxins in blood from blood by way of an extracorporeal circuit comprising a hollow-fiber filter module and polymer sorbent in combination.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: December 21, 2021
    Assignee: CYTOSORBENTS CORPORATION
    Inventors: Wei-Tai Young, Tamaz Guliashvili, Andrew Scheirer, Josh Vichare, Timothy Kovacs, Maryann Gruda, Thomas Golobish, Vincent Capponi, Phillip Chan
  • Publication number: 20210308241
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Application
    Filed: March 15, 2021
    Publication date: October 7, 2021
    Inventors: Timothy A. Chan, Naiyer A. Rizvi, Matthew D. Hellmann
  • Publication number: 20210295742
    Abstract: Exemplary embodiments include systems and methods for simulating a medical procedure. The simulator may approximate a portion of the body including the vasculature for providing simulation of accessing the vasculature in the medical procedure. The simulator may therefore include any combination of pump(s), conduit(s), reservoir(s), valve(s), body material, coverings, etc.
    Type: Application
    Filed: March 22, 2021
    Publication date: September 23, 2021
    Inventors: Timothy Chan, Jason Kiyoshi Chan
  • Publication number: 20210266642
    Abstract: Mechanisms are provided for character-based and image-based media content search and discovery. Character images or entity images are mapped to corresponding media content. Selection of an image or a portion of an image may trigger or search for corresponding media content or begin playback of relevant media content. Character images or entity images need not correspond to a primary program character or object but may correspond to minor characters or tangential entities depicted periodically on particular programs.
    Type: Application
    Filed: September 28, 2020
    Publication date: August 26, 2021
    Inventors: John Hinman, Ray DeRenzo, Timothy Chan, Allen Billings, Stephen Coney, David Brubeck
  • Publication number: 20210188809
    Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production. Formula (I) The compounds are IRAK-4 inhibitors useful for treating an inflammatory disease, an autoimmune disease, cancer, a cardiovascular disease, a disease of the central nervous system, a disease of the skin, an ophthalmic disease and condition, and a bone disease.
    Type: Application
    Filed: January 18, 2017
    Publication date: June 24, 2021
    Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffrey Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph P. Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield, Nathan Genung
  • Patent number: 10993998
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: May 4, 2021
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Timothy A. Chan, Naiyer A. Rizvi, Matthew D. Hellmann
  • Patent number: 10812863
    Abstract: Mechanisms are provided for character-based and image-based media content search and discovery. Character images or entity images are mapped to corresponding media content. Selection of an image or a portion of an image may trigger or search for corresponding media content or begin playback of relevant media content. Character images or entity images need not correspond to a primary program character or object but may correspond to minor characters or tangential entities depicted periodically on particular programs.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: October 20, 2020
    Assignee: MobiTV, Inc.
    Inventors: John Hinman, Ray DeRenzo, Timothy Chan, Allen Billings, Stephen Coney, David Brubeck
  • Publication number: 20200232040
    Abstract: Systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen are provided. Sequencing reads are obtained from samples from the subject representative of the cancer. A human leukocyte antigen type and a plurality of clones is determined from the sequencing reads. For each clone, an initial frequency X? in the one or more samples is determined and a corresponding clone fitness score of the clone is computed, thereby computing clone fitness scores. Each such fitness score is computed by identifying neoantigens in the respective clone, computing a recognition potential for each neoantigen, and determining the corresponding clone fitness score of the respective clone as an aggregate of these recognition potentials. A total fitness, quantifying the likely responsiveness of the subject to the regimen, is computed by summing the clone fitness scores across the plurality of clones.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 23, 2020
    Inventors: Marta Luksza, Vinod P. Balachandran, Arnold J. Levin, Jedd D. Wolchok, Taha Merghoub, Steven D. Leach, Timothy A. Chan, Benjamin D. Greenbaum, Michael Laessig
  • Patent number: 10577367
    Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: March 3, 2020
    Assignee: BIOGEN MA INC.
    Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
  • Publication number: 20200040049
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Application
    Filed: February 22, 2019
    Publication date: February 6, 2020
    Inventors: Timothy A. Chan, Naiyer A. Rizvi, Matthew D. Hellmann
  • Publication number: 20190263910
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Application
    Filed: September 22, 2017
    Publication date: August 29, 2019
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Timothy A. CHAN, Nadeem RIAZ
  • Publication number: 20190248787
    Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 15, 2019
    Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
  • Publication number: 20190119268
    Abstract: The present invention provides compounds useful as inhibitors of PDK1. The present invention also provides compositions thereof, and methods of treating PDK1-mediated diseases.
    Type: Application
    Filed: May 23, 2018
    Publication date: April 25, 2019
    Inventors: Joseph ARNDT, Timothy CHAN, Kevin GUCKIAN, Gnanasambandam KUMARAVEL, Wen-Cherng LEE, Edward Yin-Shiang LIN, Daniel SCOTT, Lihong SUN, Jermaine THOMAS, Kurt VAN VLOTEN, Deping WANG, Lei ZHANG, Daniel ERLANSON
  • Patent number: 10268269
    Abstract: The present invention is directed to a glove system comprising a plurality of closed tip finger sheath with a secondary finger sheath disposed near the finger tips to allow for improved interaction with a portable electronic devices.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: April 23, 2019
    Inventor: Timothy Chan
  • Patent number: 10246456
    Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: April 2, 2019
    Assignee: BIOGEN MA INC.
    Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
  • Publication number: 20190092864
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Application
    Filed: September 25, 2018
    Publication date: March 28, 2019
    Inventors: Timothy A. Chan, Diego Puente Chowell, Robert M. Samstein, Luc Morris
  • Publication number: 20190062394
    Abstract: The present invention relates to modified forms of IL-12. These modified forms of IL-12 may be engineered to have a shortened in vivo half-life compared and/or enhanced localization of biological effects compared to that of corresponding non-modified form of IL-12. Short half-life and membrane bound forms of IL-12 may provide greater therapeutic control for in vivo therapeutic delivery, in particular when used in combination with ligand inducible delivery of IL-12. Modified forms of IL-12 engineered to have shortened in vivo half-life and/or enhanced localization of biological effects include heterodimeric p35/p40, single chain and membrane bound forms of IL-12 wherein a naturally occurring IL-12 amino acid sequence is genetically modified to destabilize IL-12 tertiary structure/polypeptide folding and enhance susceptibility of the IL-12 molecule to in vivo proteolytic degradation.
    Type: Application
    Filed: October 10, 2016
    Publication date: February 28, 2019
    Applicant: Intrexon Corporation
    Inventors: Ramya YARLAGADDA, Charles REED, Charles Andrew (Marshall) STEWART, Peter EMTAGE, Rutul SHAH, Timothy CHAN
  • Publication number: 20180310652
    Abstract: A pocket for a garment comprising a first compartment and secondary compartment adapted to storing a smart phone.
    Type: Application
    Filed: April 26, 2017
    Publication date: November 1, 2018
    Inventor: Timothy Chan
  • Publication number: 20180291074
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Application
    Filed: November 23, 2015
    Publication date: October 11, 2018
    Inventors: Timothy A. Chan, Naiyer A. Rizvi, Matthew D. Hellmann